CMFRI to commercialise seaweed-based product for treating fatty liver disease

  • December 28, 2022
  • 1

Inks MoU with Kerala-based company Emineotech The ICAR-Central Marine Fisheries Research Institute (CMFRI) has announced that Cadalmin LivCure extract, a patent-protected nutraceutical product developed by the researchers at CMFRI from seaweeds, against non-alcoholic fatty liver disease,